Abstract
Pseudomonas aeruginosa shows multidrug resistance, which is mainly attributable to its expression of xenobiotic efflux pumps. However, it is unclear how silent pumps are expressed in clinical isolates. Here, we sequenced the complete genome of P. aeruginosa strain 8380, which was isolated from a human gut.
GENOME ANNOUNCEMENT
Pseudomonas aeruginosa, a prevalent Gram-negative pathogen, is a key causative agent of acute and chronic infections in immunocompromised hosts (1). This organism shows multidrug resistance, which is mainly attributable to the interplay of low outer membrane permeability and the intrinsic expression of the resistance-nodulation-cell division (RND)-type efflux pumps (2, 3). A multidrug-resistant mutant, the NfxC-type mutant, shows resistance to chloramphenicol and fluoroquinolones via the induction of one of the most clinically significant RND-type efflux pumps, MexEF-OprN, and to imipenem via the reduction of OprD porin on cells (4, 5). This phenotype is caused by MexT, which is one of major global regulators in P. aeruginosa (5–7). We previously reported that the activation of MexT in clinically isolated 8380 differs from that of PAO1 (7, 8). MexT is inactive in PAO1 and 8380 cells under laboratory conditions because PAO1 has an impaired mexT locus, whereas 8380 has an unimpaired mexT locus and a higher activity of the MexT repressor, mexS8380 (7, 8). Thus, a mutation in mexS is required for activation of MexT and expression of MexEF-OprN in 8380 (8). We have also reported that the sequence of mexS8380 contains an important substitution, G745A, which changes an amino acid, and D249N, which increases its activity compared with that of mexS PAO1 (8).
Here, we announce the complete genome sequence of the clinical isolate P. aeruginosa strain 8380. The 8380 genome was sequenced using a Pacific Biosciences PacBio RSII sequencer. A total of 75,207 reads, averaging 8,691 bp in length, were obtained for a total of 653,628,053 bases of sequence. Genome assembly was performed with the RS_HGAP_Assembly.3 protocol, and a single contig was obtained. The assembled sequence of the 8380 genome comprised a single circular chromosome of 6,613,159 bp. The average GC content of the chromosome was 66.2%, which is consistent with other P. aeruginosa strains previously sequenced. Automated genome annotation was carried out by means of both Prokka and RAST (9). In addition to these automated annotations, protein sequences were queried against the Swiss-Prot database using BLASTp, and the annotation was manually curated. The complete 8380 genome has 6,210 protein-coding sequences, 63 tRNA genes, 12 rRNA genes, and a single transfer-messenger RNA (tmRNA) gene. Twelve RND-type efflux pumps, which were discovered in PAO1, were predicted in the 8380 genome (10, 11). Among them, MexAB-OprM, MexCD-OprJ, and MexXY efflux pumps are overexpressed by one or more mutations in the repressors mexR, nfxB, and mexZ, respectively, each of which contributes to antibiotic resistance (12–14). mexR and nfxB in 8380 each had one synonymous substitution, C67A or T555G, respectively, and mexZ contained no mutations compared with those in PAO1. Moreover, 8380 cells showed antibiotic susceptibility comparable with that of PAO1 cells (4, 8). More detailed analyses of the 8380 genome are ongoing.
Nucleotide sequence accession number.
The complete 8380 genome sequence had been deposited in DDBJ under the accession no. AP014839.
ACKNOWLEDGMENT
This research was supported by a Grant-in-Aid for Scientific Research (C).
Footnotes
Citation Ichise Y-K, Kosuge T, Uwate M, Nakae T, Maseda H. 2015. Complete genome sequence of Pseudomonas aeruginosa strain 8380, isolated from the human gut. Genome Announc 3(3):e00520-15. doi:10.1128/genomeA.00520-15.
REFERENCES
- 1.Rehm BHA (ed). 2008. Pseudomonas; model organism, pathogen, cell factory. Wiley-VCH Verlag GmbH & Co KGaA, Weinheim, Germany. [Google Scholar]
- 2.Breidenstein EB, de la Fuente-Núñez C, Hancock RE. 2011. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol 19:419–426. doi: 10.1016/j.tim.2011.04.005. [DOI] [PubMed] [Google Scholar]
- 3.Fernández L, Hancock RE. 2012. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev 25:661–681. doi: 10.1128/CMR.00043-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Masuda N, Sakagawa E, Ohya S. 1995. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 39:645–649. doi: 10.1128/AAC.39.3.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Köhler T, Epp SF, Curty LK, Pechère JC. 1999. Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol 181:6300–6305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Galán-Vásquez E, Luna B, Martínez-Antonio A. 2011. The regulatory network of Pseudomonas aeruginosa. Microb Inform Exp 1:3. doi: 10.1186/2042-5783-1-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Maseda H, Saito K, Nakajima A, Nakae T. 2000. Variation of the mexT gene, a regulator of the MexEF-OprN efflux pump expression in wild-type strains of Pseudomonas aeruginosa. FEMS Microbiol Lett 192:107–112. doi: 10.1111/j.1574-6968.2000.tb09367.x. [DOI] [PubMed] [Google Scholar]
- 8.Uwate M, Ichise YK, Shirai A, Omasa T, Nakae T, Maseda H. 2013. Two routes of MexS-MexT-mediated regulation of MexEF-OprN and MexAB-OprM efflux pump expression in Pseudomonas aeruginosa. Microbiol Immunol 57:263–272. doi: 10.1111/1348-0421.12032. [DOI] [PubMed] [Google Scholar]
- 9.Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL, Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O. 2008. The RAST server: rapid annotations using subsystems technology. BMC Genomics 9:75. doi: 10.1186/1471-2164-9-75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Smith KC, Spencer D, Wong GK-S, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock REW, Lory S, Olson MV. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959–964. doi: 10.1038/35023079. [DOI] [PubMed] [Google Scholar]
- 11.Lister PD, Wolter DJ, Hanson ND. 2009. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22:582–610. doi: 10.1128/CMR.00040-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Adewoye L, Sutherland A, Srikumar R, Poole K. 2002. The mexR repressor of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: characterization of mutations compromising activity. J Bacteriol 184:4308–4312. doi: 10.1128/JB.184.15.4308-4312.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Poole K, Gotoh N, Tsujimoto H, Zhao Q, Wada A, Yamasaki T, Neshat S, Yamagishi J, Li XZ, Nishino T. 1996. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug resistant strains of Pseudomonas aeruginosa. Mol Microbiol 21:713–724. doi: 10.1046/j.1365-2958.1996.281397.x. [DOI] [PubMed] [Google Scholar]
- 14.Islam S, Jalal S, Wretlind B. 2004. Expression of MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 10:877–883. doi: 10.1111/j.1469-0691.2004.00991.x. [DOI] [PubMed] [Google Scholar]